Skip to main content

Introduction to In Vivo Platforms for Cancer Immunotherapy

Published Date

March 4, 2021 -  Grace Berryhill, Ph.D., provides an overview of in vivo platforms being used to improve the translational relevance of cancer immunotherapies. Covered in this webinar are:

  • Current approaches for cancer immunotherapy
  • Types of cancer immunotherapeutics that have been characterized and validated in mouse models
  • Innovative humanized platforms for immuno-oncology drug development

A recorded Q&A session begins at 54:24:17.